868 related articles for article (PubMed ID: 9224651)
21. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
Marchetti D
J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
[TBL] [Abstract][Full Text] [Related]
22. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
23. Substrate specificity of heparanases from human hepatoma and platelets.
Pikas DS; Li JP; Vlodavsky I; Lindahl U
J Biol Chem; 1998 Jul; 273(30):18770-7. PubMed ID: 9668050
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of tumor metastasis by heparanase inhibiting species of heparin.
Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T
Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522
[TBL] [Abstract][Full Text] [Related]
25. Ultrafiltration-based assay for heparanase activity.
Tsuchida S; Podyma-Inoue KA; Yanagishita M
Anal Biochem; 2004 Aug; 331(1):147-52. PubMed ID: 15246007
[TBL] [Abstract][Full Text] [Related]
26. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
[TBL] [Abstract][Full Text] [Related]
27. Maintenance on extracellular matrix and expression of heparanase activity by human ovarian carcinoma cells from biopsy specimens.
Peretz T; Antebi SU; Beller U; Horowitz AT; Fuks Z; Vlodavsky I
Int J Cancer; 1990 Jun; 45(6):1054-60. PubMed ID: 2190937
[TBL] [Abstract][Full Text] [Related]
28. Differentiating human leukemia cells express heparanase that degrades heparan sulfate in subendothelial extracellular matrix.
Yahalom J; Fibach E; Bar-Tana R; Fuks Z; Vlodavsky I
Leuk Res; 1988; 12(9):711-7. PubMed ID: 2973542
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization of heparanase in human neutrophils.
Matzner Y; Vlodavsky I; Bar-Ner M; Ishai-Michaeli R; Tauber AI
J Leukoc Biol; 1992 Jun; 51(6):519-24. PubMed ID: 1613389
[TBL] [Abstract][Full Text] [Related]
30. Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity.
Nardella C; Steinkühler C
Anal Biochem; 2004 Sep; 332(2):368-75. PubMed ID: 15325306
[TBL] [Abstract][Full Text] [Related]
31. CXC chemokines connective tissue activating peptide-III and neutrophil activating peptide-2 are heparin/heparan sulfate-degrading enzymes.
Hoogewerf AJ; Leone JW; Reardon IM; Howe WJ; Asa D; Heinrikson RL; Ledbetter SR
J Biol Chem; 1995 Feb; 270(7):3268-77. PubMed ID: 7852412
[TBL] [Abstract][Full Text] [Related]
32. Heparanase: Historical Aspects and Future Perspectives.
Khanna M; Parish CR
Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
[TBL] [Abstract][Full Text] [Related]
33. Human prostate carcinoma cells produce extracellular heparanase.
Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
[TBL] [Abstract][Full Text] [Related]
34. Partial purification of heparanase activities in Chinese hamster ovary cells: evidence for multiple intracellular heparanases.
Bame KJ; Hassall A; Sanderson C; Venkatesan I; Sun C
Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):191-200. PubMed ID: 9806900
[TBL] [Abstract][Full Text] [Related]
35. Degranulating mast cells secrete an endoglycosidase that degrades heparan sulfate in subendothelial extracellular matrix.
Bashkin P; Razin E; Eldor A; Vlodavsky I
Blood; 1990 Jun; 75(11):2204-12. PubMed ID: 1693299
[TBL] [Abstract][Full Text] [Related]
36. Degradation of heparan sulfate in the subendothelial extracellular matrix by a readily released heparanase from human neutrophils. Possible role in invasion through basement membranes.
Matzner Y; Bar-Ner M; Yahalom J; Ishai-Michaeli R; Fuks Z; Vlodavsky I
J Clin Invest; 1985 Oct; 76(4):1306-13. PubMed ID: 2997275
[TBL] [Abstract][Full Text] [Related]
37. Synthesis of simple heparanase substrates.
Pearson AG; Kiefel MJ; Ferro V; von Itzstein M
Org Biomol Chem; 2011 Jun; 9(12):4614-25. PubMed ID: 21505696
[TBL] [Abstract][Full Text] [Related]
38. A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence.
Enomoto K; Okamoto H; Numata Y; Takemoto H
J Pharm Biomed Anal; 2006 Jun; 41(3):912-7. PubMed ID: 16495030
[TBL] [Abstract][Full Text] [Related]
39. Role of heparanase in platelet and tumor cell interactions with the subendothelial extracellular matrix.
Eldor A; Bar-Ner M; Yahalom J; Fuks Z; Vlodavsky I
Semin Thromb Hemost; 1987 Oct; 13(4):475-88. PubMed ID: 3321438
[TBL] [Abstract][Full Text] [Related]
40. Relationships between heparanase activity and increasing metastatic potential of fibroblasts transfected with various oncogenes.
Schwarz LC; Inoue T; Irimura T; Damen JE; Greenberg AH; Wright JA
Cancer Lett; 1990 Jun; 51(3):187-92. PubMed ID: 2350761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]